INBICON A/S: Financial statements 2022
CVR: 27036635
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
INBICON A/S (CVR 27036635) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -498,000 and a net result of DKK -319,000 compared with DKK -1,611,000 the year before. Equity in the 2022 report amounted to DKK 31,682,000. The solvency ratio was 99.9%.
- Revenue
- DKK 0
- Gross Profit
- DKK -498,000
- Profit/Loss
- DKK -319,000
- Equity
- DKK 31,682,000
- Total Assets
- DKK 31,703,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 0 | -498 t. | -319 t. | 31.7 mio. | - |
| 2021 | 0 | -518 t. | -1.6 mio. | 32 mio. | - |
| 2020 | 0 | 25.7 mio. | 21.3 mio. | 33.6 mio. | - |
| 2019 | - | 4.6 mio. | 3.5 mio. | 12.3 mio. | - |
| 2018 | - | -16.3 mio. | -12.7 mio. | 8.8 mio. | - |
Official annual report
Keep an eye on INBICON A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
INBICON A/S has published its annual report for 2021. Revenue came to DKK 0, and the net result was DKK -1,611,000.
About INBICON A/S
INBICON A/S is a Danish company of the type Aktieselskab based in Fredericia, founded in 2003. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ELSAM BIOSYSTEMS A/S and KR 354 A/S. The management consists of Thomas Søndergaard Lyse. The board consists of Ole Thomsen (chair), Jens Grymer and Thomas Søndergaard Lyse. The company is owned by Ørsted New Bio Solutions Holding A/S. The company has 0 employees (2011). In 2025, the company reported a net result of DKK -3,447,000 compared with DKK 7,237,000 the year before. Equity in the 2025 report amounted to DKK 35,752,000.